Establishing a prediction model for prostate cancer bone metastasis

Area of Science:

• Urology
• Oncology
• Medical Imaging

Background:

• Prostate cancer (PCa) bone metastasis (BM) significantly impacts patient prognosis and treatment decisions.
• Accurate prediction of BM is crucial for timely intervention and avoiding unnecessary diagnostic procedures like bone scans.

Purpose of the Study:

• To investigate clinical characteristics and independent risk factors for PCa bone metastasis (BM).
• To establish a prediction model for PCa BM to guide the necessity of bone scans.
• To evaluate the impact of PI-RADS v2 scores on the prediction model's accuracy.

Main Methods:

• Retrospective analysis of clinical data from 308 PCa patients.
• Univariate and multivariate logistic regression analyses using factors like Gleason score, tumor stage, PSA levels, and alkaline phosphatase.
• Inclusion of PI-RADS v2 scores in a subset of patients (80) to refine the prediction model.

Main Results:

• Biopsy Gleason score (BGS), clinical tumor stage (cTx), total prostate specific antigen (tPSA), and alkaline phosphatase (ALP) were identified as significant independent risk factors for BM.
• A prediction model was developed, with AUC increasing from 0.884 to 0.934 upon incorporating PI-RADS v2 scores.
• Specific criteria were defined for high suspicion of BM based on combinations of BGS, cTx, ALP, and tPSA.

Conclusions:

• Clinical factors including BGS, cTx, tPSA, and ALP are crucial for predicting PCa bone metastasis.
• The PI-RADS v2 score significantly improves the accuracy of the BM prediction model.
• This validated model can assist clinicians in judiciously deciding on the necessity of bone scans for PCa patients.